Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-rBitistatin for Imaging Venous Thrombosis
NCT00808626Phase 2Withdrawn
- Sponsor
- Temple University
- Start
- Dec 2008
- Primary completion
- Mar 2017
- Modality
- Imaging
- Countries
- 1
01
Overview
A Phase 2 trial of 99mTc-rBitistatin in venous thrombosis, sponsored by Temple University. Planned start Dec 2008; status: withdrawn.
02
Drugs
99mTc-rBitistatin
03
Conditions
venous thrombosis
Beyond the preview
Go deeper on NCT00808626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808626.